logo
Search orAI Icon𝛼SK
ENTITY

X4 Pharmaceuticals (XFOR US)

7
Analysis
Health Care • United States
X4 Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. The Company specializes in developing novel therapeutics designed to improve immune cell trafficking to treat rare diseases including primary immunodeficiencies and cancer. X4's oral small molecule drug candidates antagonize the CXCR4 pathway which plays a central role in immune surveillance.
more
Company Event • 26 Mar 2026 00:30 • Upcoming
Add To Calendar

Q4 2025

Company Event • 10 Nov 2025 21:30 • Latest

Guggenheim Securities 2nd Annual Healthcare Innovation Conference

Company Event • 05 Nov 2025 21:00 • Upcoming
Add To Calendar

Q3 2025

Company Event • 09 Aug 2025 04:00 • Upcoming
Add To Calendar

Q2 2025

Company Event • 01 May 2025 20:30

Q1 2025

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.59.7

x